Company news
Futura Medical Plc (LSE:FUM) news
Futura Medical Plc news releases on 6ix. Latest, Sep 16, 2022: PDMR Dealing and Total Voting Rights
Press releases — page 3
PDMR Dealing and Total Voting Rights
September 16, 2022
Futura Medical Interim Results 2022
September 13, 2022
Notice of Interim Results
September 1, 2022
Highly positive FM71 Phase 3 Study Results
August 31, 2022
Price Monitoring Extension
July 12, 2022
Futura Medical AGM Results
June 28, 2022
Notice of AGM and Availability of Annual Report
June 1, 2022
Agreement with Cooper Consumer Health - Correction
May 23, 2022
Full Year Results 2021
April 26, 2022
Futura Medical Notice of Preliminary Results 2021
April 14, 2022
Futura Announces Collaboration with Menarini
March 23, 2022
TR-1:Notification of major holdings
February 2, 2022
Remuneration of Non-Executive Directors and TVR
January 13, 2022
US regulatory and commercial update for MED3000
December 20, 2021
Futura Medical plc Total Voting Rights
November 30, 2021
Futura Medical plc Board Appointment
October 28, 2021
Director/PDMR Shareholding
October 5, 2021
Interim Results for Six Months ended 30 June 2021
September 29, 2021
Futura Announces Collaboration with Labatec Pharma
September 27, 2021
First Patient visit in MED3000 Confirmatory Study
September 15, 2021
TR1: Notification of Major Holdings
September 8, 2021
Futura Medical Announces Collaboration of MED3000
August 31, 2021
FDA regulatory and commercial update for MED3000
July 19, 2021
Notice of AGM and Annual Report
June 3, 2021
Result of General Meeting & Total Voting Rights
June 2, 2021
Posting of Circular and Notice of General Meeting
May 17, 2021
Retail Offer by PrimaryBid
May 14, 2021
Futura Receives Approval from EU Notified Body
April 30, 2021
Correction - Conversion of Convertible Loan Notes
April 19, 2021
Conversion of Convertible Loan Notes
April 15, 2021
Full Year Results for the year ended 31 Dec 2020
April 14, 2021
Exercise of Warrants, Issue of Equity & TVR
April 1, 2021
US FDA Agreement for Confirmatory Clinical study
March 22, 2021
Futura Receives Recommendation for Approval
March 19, 2021
Futura Announces Investment & Joint Collaboration
March 4, 2021
Futura provides US regulatory & commercial update
December 8, 2020
Futura provides regulatory and commercial update
October 22, 2020
Interim Results for Six Months ended 30 June 2020
September 16, 2020
Futura receives positive QMS Audit Opinion
August 10, 2020
Futura update on CBD100 1st Stage Development Work
August 4, 2020
Futura Medical provides EU & US regulatory update
July 14, 2020
Block listing Interim Review - Replacement
July 10, 2020
Trading Statement
June 24, 2020
Block listing Interim Review
June 1, 2020
Futura files for Further Pre-Submission meeting
April 20, 2020
Futura Confirms Receipt of US FDA Minutes
April 6, 2020
Full Year Results for the year ended 31 Dec 2019
April 1, 2020
Futura to Update on MED3000 at Investor Seminar
March 5, 2020
Update on positive EU regulatory discussions
February 13, 2020
Remuneration of NED and Total Voting Rights
January 22, 2020